Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden
· Delayed Price · Currency is SEK 9.62
-0.26 (-2.63%)
At close: Dec 5, 2025
Diamyd Medical AB Income Statement
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | 2020 - 2016 |
| Revenue | 0.13 | 0.13 | 0.55 | 0.45 | 0.25 | Upgrade
|
| Revenue Growth (YoY) | - | -76.19% | 20.26% | 79.45% | -25.81% | Upgrade
|
| Cost of Revenue | 3.84 | 3.71 | 3.63 | 4.4 | 2.5 | Upgrade
|
| Gross Profit | -3.71 | -3.58 | -3.09 | -3.95 | -2.25 | Upgrade
|
| Selling, General & Admin | 56.55 | 44.79 | 39.7 | 31.93 | 25.63 | Upgrade
|
| Research & Development | 119.5 | 96.48 | 69.91 | 75.57 | 56.86 | Upgrade
|
| Other Operating Expenses | -3.03 | -3.16 | -1.72 | -0.89 | 0.55 | Upgrade
|
| Operating Expenses | 179.53 | 143.69 | 112.76 | 110.99 | 83.82 | Upgrade
|
| Operating Income | -183.23 | -147.27 | -115.85 | -114.94 | -86.07 | Upgrade
|
| Interest Expense | - | -0.01 | -0 | -0.25 | -0.45 | Upgrade
|
| Interest & Investment Income | 2.34 | 3.75 | 1.05 | 0.07 | 0 | Upgrade
|
| Earnings From Equity Investments | - | 6.12 | -4.96 | -3.24 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 4.16 | 0.12 | 3.68 | 8.19 | 2.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | 0 | -0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -176.73 | -137.3 | -116.07 | -110.17 | -84.37 | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.96 | -9.14 | - | 6.65 | 144.41 | Upgrade
|
| Asset Writedown | - | -5.41 | - | - | - | Upgrade
|
| Pretax Income | -169.78 | -151.85 | -116.07 | -103.52 | 60.05 | Upgrade
|
| Net Income | -169.78 | -151.85 | -116.07 | -103.52 | 60.05 | Upgrade
|
| Net Income to Common | -169.78 | -151.85 | -116.07 | -103.52 | 60.05 | Upgrade
|
| Net Income Growth | - | - | - | - | 518.46% | Upgrade
|
| Shares Outstanding (Basic) | 113 | 95 | 78 | 77 | 70 | Upgrade
|
| Shares Outstanding (Diluted) | 113 | 95 | 78 | 77 | 70 | Upgrade
|
| Shares Change (YoY) | 18.81% | 20.98% | 2.29% | 9.65% | 0.90% | Upgrade
|
| EPS (Basic) | -1.51 | -1.60 | -1.48 | -1.35 | 0.86 | Upgrade
|
| EPS (Diluted) | -1.51 | -1.60 | -1.48 | -1.35 | 0.86 | Upgrade
|
| EPS Growth | - | - | - | - | 512.92% | Upgrade
|
| Free Cash Flow | -179.73 | -137.21 | -122.4 | -127.87 | -113.69 | Upgrade
|
| Free Cash Flow Per Share | -1.60 | -1.45 | -1.56 | -1.67 | -1.63 | Upgrade
|
| Operating Margin | -140949.23% | -113287.69% | -21217.22% | -25316.30% | -34020.55% | Upgrade
|
| Profit Margin | -130597.69% | -116807.69% | -21258.79% | -22801.10% | 23733.60% | Upgrade
|
| Free Cash Flow Margin | -138254.61% | -105543.08% | -22418.32% | -28165.42% | -44937.94% | Upgrade
|
| EBITDA | -176.73 | -141.69 | -110.98 | -110.55 | -85.29 | Upgrade
|
| D&A For EBITDA | 6.5 | 5.58 | 4.87 | 4.38 | 0.78 | Upgrade
|
| EBIT | -183.23 | -147.27 | -115.85 | -114.94 | -86.07 | Upgrade
|
| Revenue as Reported | 5.02 | 4.36 | 3.75 | 2.58 | 0.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.